Views
8 years ago

Psicofarmacología 77

  • Text
  • Psiquiatricas
  • Sintomatologia
  • Neuronales
  • Paroxiticos
  • Epilepsia
  • Medicacion
  • Comorbilidades
  • Evolucion
  • Riesgo
  • Tdah
  • Vejez
  • Negativas
  • Positivas
  • Procesamiento
  • Emocion
Revista Latinoamericana de Psicofarmacología y Neurociencia.

Dra. Laura Verónica

Dra. Laura Verónica Galván minutos. 3B) reporte del cese total de las crisis corroborado por un familiar o cuidador. Además, hay criterios de soporte: a) Cambio reciente del plan farmacológico (dentro de los últimos 30 días). b) Reporte, por parte de un familiar, médico o historia clínica, de episodios de cesación de las crisis con alteraciones de la conducta previos, con o sin registos de EEG. Para hacer diagnóstico debe estar el criterio principal 1, 2 y 3A, o bien el criterio principal 1, 2, 3B y un criterio de soporte (32). Referencias bibliográficas 1. D´Alessio L. Psicosis y Epilepsia, Clínica y Terapéutica. Tratado de Psicofarmacología y Neurociencia, Vol. III. Editorial Sciens, 2011. 2. Kanner AM. The Behavioral Aspects of Epilepsy: An Overview of Controversial Issues. Epilepsy & Behavior 2, B-12, 2001. 3. D´Alessio L, Analysis of psychotic disorders in patients with refractory partial epilepsy, psichiatric diagnoses and clinical aspects. Actas Esp Psiquiatr 36:138-143. 2008. 4. D´Alessio L, Psychotic disorders in Argentine patients with refractory temporal lobe epilepsy: A case control stusy. Epilepsy & Behavior 14:604-609. 2009. 5. D´Alessio, L. La psicosis epiléptica, modelos neurobiológicos e implicancias farmacológicas. Psicofarmacología. 8: 12-16. 14. 2001 6. Siddhartha N, Psychosis in epilepsy patients. Epilepsia, 48 Suppl. 9:17–19, 2007. 7. Tugendhaft P,Guidelines for recognition and treatment of the psychoses associated with epilepsy. Acta Neurol Belg. 105:14-17, 2005. 8. Logsdail S,Postictal psychosis: a clinical and phenomenological description. Br J Psychiatry 152:246-252. 1988. 9. Perminder S, Alternating and postictal psychosis: review and unifying hypothesis. Schizophrenia Bulletin vol 33 1029-1033, 2007. 10. Krishnamoorthy, E.S., Trimble, M.R., Sander, J.W.A.S., Kanner, A. Forced normalization at the interface between epilepsy and psychiatry. Epilepsy & Behavior 3, 303-308, 2002. 11. Alper KR, Barry J, Balabanov AJ. Treatment of psychosis, aggression, and irritability in patients with epilepsy. Epilepsy & Behavior. 3:S13-S18. 2002. 12. Farkas M, Baran B, Karpati R. et al. Utility of electroshock therapy in epilepsy-associated psychosis. Seizure. 55:400-405. 2002. 13. Kanner AM, Depression and Epilepsy: a new prospective on two closely related disorders. Epilepsy Currents 6(5):141-146. 2006. 14. Seethalakshmi R, Krishnamoorthy E. Depression in epilepsy: phenomenology, diagnosis, and management. Epileptic Disord. 9(1):1- 10. 2007. 15. Gonçalves E, Cendes F. Depression in patients with refractory temporal lobe epilepsy. Arq Neuropsiquiatr. 69(5):775-777. 2011. 16. Blummer D, Altshuler LL. Affective Disorders. In: Epilepsy: A comprehensive textbook, vol II (Engel J, Pedley TA, eds.) Philadelphia: Lippincott-Raven, 1998:2083- 2099. 17. Kanner AM, Wuu J, Barry J,Hermann B, Meador KJ, Guilliam F. Atypical depressive episodes in epilepsy: a study of their clinical characteristics and impact on quality of life. Neurology. 62 (suppl5):A249. 2004. 18. Kanner AM, Depression and Epilepsy: A review of multiple facets of their close relation. Neurology clinics 27:865-880. 2009. 19. Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: Is it safe? Epilepsy & Behavior 1:100-5, 2000. 20. Mula M, Depression in epilepsy: Mechanisms and therapeutic approach. Ther Adv Neurol Disord 2(5):337-344, 2009. 21. Boylan LS, Flint LA, Labovitz L, et al. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology. 62(2):258–61. 2004. 22. Gilliam F, Kuzniecky R, Faught E, et al. Patient-validated content of epilepsyspecific quality-of-life measurement. Epilepsia. 38(2):233–6.1997. 23. Cramer JA, Blum M, Reed M, et al. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav;4:515–21. 2003. 24. Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 75:192–6. 2007. 25. Kanner AM, Byrne R, Chicharro A, et al. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 72:793–9. 2009. 26. Christensen J, Vestergaard M, Mortensen P, et al. Epilepsy and risk of suicide: a populationbased case–control study. Lancet Neurol. 6:693–8. 2007. 27. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Ann Neurol. 59:35–41. 2006. 28. Kanner AM, Soto A, Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology. 62:708–13. 2004. 29. Jones JE, Hermann BP, Barry JJ, et al. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav.4:S31–8. 2003. 30. Hesdorffer DC, Hauser WA, Annegers JF and Cascino, G. Major depression is a risk factor for seizures in older patients. Ann Neurol. 47: 246- 249. 2000. 31. Mohanraj R, Brodie MJ. Predicting outcomes in newly diagnosed epilepsy. Epilepsia. 44(suppl 9):15 (abst.). 2003. 32. Krishnamoorthy, E. S., Trimble, M.R. Forced Normalization: Clinical and Therapeutic Relevance. Epilepsia 40 (Suppl. 10):S57-S64, 1999. 38 // EDITORIAL SCIENS

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015